+27 (0)12 844 0144 info@vxpharma.com

Heading

General Comments:

  • Should there be a general re-brand? New name, logo, CI etc? VX Gas reference? LEAVE THIS COMPONENT FOR NOW
  • Too much content on all pages
  • Font too small
  • Do we mention Ampath and Aurum relationships? Definitely mention formal alliance with Aurum Institute – place some content relating to AI & link. New tab – ‘STRATEGIC ALLIANCES’ – discuss w Ampath
  • How are we dealing with Syzygy? At the least we need to mentimon a 100% acquisition of them and incorporation into VXP Definitely, to fall under the news section. GRAPHIC TIMELINE – note Syzygy acquisition
  • BBBEE claims – with dilution by Ampath how do we manage this?? REMOVE CONTENT & REFERENCES
  • Do we keep general news channels open and live? Who manages these? Can we automate?
  • NEWS FEEDS – RELEASE OF NEW DRUGS THAT WE HAVE BEEN INVOLVED IN TRIALS IN, SAHPRA, REGULATORY ENVIRONMENT ETC.
  • carley@in-detail.com

View our pdf